Article
Antiplatelet therapy may decrease HCC incidence and improve post-treatment outcomes
Article
Hepatectomy recommended for select patients with multiple HCC
Article
Ramucirumab effective in patients with advanced HCC and AFP ≥400 ng/mL after non-sorafenib therapies
Article
Unresectable HCC: Atezolizumab plus bevacizumab proves its worth in the clinic
Article
Alpha-fetoprotein: A real-time monitor in HCC treatment with atezolizumab and bevacizumab
Article
Unrecognized liver cirrhosis common, associated with worse prognosis in HCC
News
Ulcerative colitis: Reassuring findings on long-term tofacitinib reported
After evaluation of an additional 3.4 years of observation, the authors found the safety profile of tofacitinib remained consistent with increased...